Esperion Therapeutics
ESPR
#6416
Rank
โ‚น73.05 B
Marketcap
โ‚น305.60
Share price
0.90%
Change (1 day)
112.49%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น73.05 Billion

As of February 2026 Esperion Therapeutics has a market cap of โ‚น73.05 Billion. This makes Esperion Therapeutics the world's 6416th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น73.05 B-15.03%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Feb 26th, 2026 the market cap of Esperion Therapeutics was reported to be:

โ‚น73.05 Billion
by Nasdaq info icon info icon
โ‚น73.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.014 T 19,082.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.411 T 10,044.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น202.49 B 177.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น57.00 B-21.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น408.86 B 459.65%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.067 T 1,361.57%๐Ÿ‡บ๐Ÿ‡ธ USA